Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Institut Du Cancer de Montpellier, Montpellier